< Back to the list of products
Poulvac IB Primer, Oral Solution or Spray Solution for Chickens.
- Unique combination of 2 IB strains (H120 and D274), Poulvac IB Primer provides a wide broad spectrum against the most relevant IB strains.1 IBV population is always evolving by genetic recombination as all corona viruses. Poulvac IB Primer by bringing 2 vaccine strains and with day old claim brings early and excellent protection against field challenge. The day of age claim is the guarantee of safety you should expect from IB vaccines.
- With Poulvac IB Primer, Poulvac IBMM+Ark, Poulvac IBMM and Poulvac IB H120, FDAH offers the most complete range of IB vaccines in order to adapt the vaccination schedule to the field situation with the best economical return.
1 Jones R.J., Worthington K.J., Capua I., Naylor C.J., "Efficacy of live infectious bronchitis vaccines
against a novel European genotype Italy 02", Veterinary Record, 2005, 156, 646-647
Wijmenga W.J.H., "Results of pan-european survey on infectious bronchitis and efficacy of vaccination
against challenge with QX-like IBV", FDAH technical bulletin, 2006
Description
Oral solution or spray solution after reconstitution of the freeze-dried vaccine in water for chickens
| Active Ingredients: | Per dose | |
|---|---|---|
| Infectious bronchitis virus strain H120 | 103.0 - 105.4 EID50 | |
| Infectious bronchitis virus strain D274 clone | 103.0 - 105.4 EID50 | |
INDICATIONS
For active immunisation of chickens to reduce upper respiratory tract infections caused by
strains of the Massachusetts serotype and Dutch variant strains D207/D274.
The onset of immunity is from 27 days post vaccination.
Protection of chicks will be of approximately 16 weeks duration at which age the chickens
may be vaccinated with an appropriate inactivated IBV vaccine product.
CONTRAINDICATIONS
Do not use in sick chickens.
ADVERSE REACTIONS
A mild vaccination reaction can be observed in the form of transient, slight respiratory symptoms such as occasional sneezing and coughing. No harmful clinical effects have been observed. Tracheal histopathology revealed very low scores in the post vaccination period.
TARGET SPECIES
Chickens from one day of age.
DOSAGE, ROUTE AND METHOD OF ADMINISTRATION
One dose per chicken to be administered with drinking water or by spray. The quantity of
water to be used depends on the method of administration. Never use less than 1 dose per
bird.
Drinking water
Discontinue any drinking water medication 24 hours before vaccination. Water containing a
high level of free chlorine should not be used. A general indication is that if chlorine can be
detected in the water by smell or taste it could deactivate the living virus.
If so, half a litre (1 pint) of skimmed milk should be thoroughly mixed into every 20 litres (5
gallons) of water or skimmed milk powder added at a rate of two grams per litre of water
before adding vaccine.
Only perfectly clean and rust free utensils and drinkers (preferably plastic) should be used,
and disinfectants must not be used for cleaning. Ensure that there is enough drinking trough
space to allow all birds immediate access to the vaccine. No untreated water should be
available until the treated water has been consumed.
Withhold drinking water for 2 hours before vaccination to stimulate thirst. Remove the
aluminium seal from the vaccine vial. To dissolve the vaccine pellet, the rubber stopper
should then be removed whilst the vial is immersed in a plastic measuring jug containing 1
litre (approximately 1 quart) of clean cool water. Half fill the vial with water, replace the
stopper and shake to dissolve any remaining vaccine.
The vaccine concentrate should then be added to and thoroughly mixed with sufficient
drinking water to last for approximately 2 hours.
The approximate drinking water requirements for vaccination can be calculated from the age
of the birds. Use as many litres of water as the age of the birds in days, per 1000 birds, up to a
maximum of 40 litres per 1,000 birds.
Distribute the diluted vaccine evenly in the drinkers. Do not expose prepared drinking water
vaccine to sunlight.
Return to regular watering only after the vaccine water has been consumed. The vaccine
solution is best divided so that the drinkers are charged at least twice with vaccine to ensure a
more widespread uptake.
If nipple drinkers are employed, ensure that header tanks are continually refilled with water
containing vaccine.
The vaccine may be used in automatic watering equipment. However, the main supply should
only be turned on when all the vaccine treated water has been consumed.
NB: Check that birds are never left without water after vaccine treatment.
Spray
Poulvac IB primer has been used in most types of spray equipment. The equipment should
provide a droplet size of 0.12 to 0.15 mm diameter. The distance from the spraying head to
the bird must be approximately 50 cm. Use 0.15 to 0.5 litres of water per 1,000 birds
depending upon the type of spray equipment to be used.
The vaccine should be dissolved as described under drinking water administration. The
vaccine concentrate should then be added to the water in the sprayer tank and thoroughly
mixed.
WITHDRAWAL PERIOD
Zero days
SHELF LIFE
Shelf-life of the veterinary medicinal product as packaged for sale: 18 – 36 months. (May
vary per country)
Reconstituted vaccine should be used within 4 hours.
SPECIAL STORAGE PRECAUTIONS
Store and transport refrigerated (2oC - 8oC).
Protect from light.
Do not freeze.
SPECIAL WARNINGS
It is accepted that spray administration offers benefits over water administration in terms of
ease of application and percentage of birds vaccinated. Nevertheless, greater secondary
problems may result under certain management conditions. Spray vaccination should not be
used if intercurrent infection is suspected. It is important to consult your veterinary adviser or
Fort Dodge Animal Health technical staff before using the spray technique.
Efficacy against infectious bronchitis caused by the 4/91 (793B) UK variant IB strain has not
been demonstrated.
Maternally derived antibody (MDA) can interfere with the development of active immunity.
Where it is likely that recent field infection or vaccination of the parent flock has stimulated a
high antibody titre and consequently a high level of MDA, the timing of the vaccination
programme should be planned accordingly.
Special precautions for use in animals
Care should be taken in the planning and implementation of vaccination programmes as
vaccine virus may spread from vaccinates to non-vaccinated chickens. It is recommended
that all chickens on a site be vaccinated with this product.
Can be used before the onset of lay in chickens intended for breeding.
Safety in hens in lay has not been demonstrated. Not to be used for birds in lay (or breeding
birds).
No information is available on the safety and efficacy from the concurrent use of Poulvac IB
Primer with any other except Poulvac NDW and Poulvac SHS, administered by the spray
route to maternal antibody positive chicks. It is therefore recommended that no other
vaccines than these should be administered within 14 days before or after vaccination with the
product.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
It is recommended to spray vaccinate in a sealed cabinet. Alternatively, the eyes and face of
vaccination staff should be protected by a full facemask approved to BS2091 (e.g. a Siebe-
Gorman vista type) and eye goggles should be worn.
A helmet with filtered air circulation may be used instead of goggles and mask.
On completion operators should wash and disinfect hands in an approved disinfectant.
On completion of vaccination, all empty or part-used vials, any residual vaccine and the
materials used for vaccination should be burnt or disinfected in a disinfectant approved for
use under the Diseases of Animals (Approved Disinfectants) Orders.
OTHER INFORMATION
ATCvet code: QI01AD07
Nature and composition of immediate packaging
Nature: Type I glass (Ph.Eur) vial
Closure: Butyl rubber (Ph.Eur) and aluminium tear-off cap.
Content: Freeze-dried pellet.
Pack size: Pack of 10 vials containing 1,000, 2,000 or 5,000 doses.
Not all pack sizes may be marketed.
National label conditions must be observed by country.


